About enfuvirtide
HIV fusion inhibitor
Used for
- Used with other HIV medicines to treat HIV-1 infection when resistance or treatment failure limits options.
Usual adult dose
90 mg injected under the skin twice daily.
Usual dose in children
For ages 6–16: 2 mg/kg under the skin twice daily, maximum 90 mg per dose.
Common side effects
- Injection-site reactions, such as pain, redness, itching, or lumps
- Diarrhea, nausea, or tiredness
- Pneumonia
- Allergic reactions
Important warnings
- Must be combined with other HIV medicines; it does not cure HIV.
- Injection-site reactions are common; rotate injection sites.
- Seek urgent care for breathing difficulty, rash, fever, or facial swelling.
- Pneumonia risk may be higher in people who smoke or have lung disease.
Pregnancy
Human pregnancy information is limited; treatment decisions should consider HIV control and pregnancy-specific guidance.
Breastfeeding
Breastfeeding is generally not recommended with HIV because of transmission risk; local guidance may differ.
Interactions
- No major drug interactions are expected; enfuvirtide is not substantially processed by liver enzymes.
- Tell clinicians about all medicines, including supplements.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.